319 results match your criteria Australian prescriber[Journal]


Emicizumab for haemophilia A.

Authors:

Aust Prescr 2019 Feb 1;42(1):42. Epub 2019 Feb 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370604PMC
February 2019

Tildrakizumab for psoriasis.

Authors:

Aust Prescr 2019 Feb 13;42(1):40-41. Epub 2018 Dec 13.

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/tildra
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370602PMC
February 2019
4 Reads

Rufinamide for seizures.

Authors:

Aust Prescr 2019 Feb 13;42(1):38-39. Epub 2018 Dec 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370605PMC
February 2019
1 Read

Migalastat for Fabry disease.

Authors:

Aust Prescr 2019 Feb 13;42(1):36-37. Epub 2018 Dec 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370600PMC
February 2019

Baricitinib for rheumatoid arthritis.

Authors:

Aust Prescr 2019 Feb 13;42(1):34-35. Epub 2018 Dec 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370601PMC
February 2019
2 Reads

Apalutamide for prostate cancer.

Authors:

Aust Prescr 2019 Feb 13;42(1):32-33. Epub 2018 Dec 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370612PMC
February 2019

Alirocumab for hypercholesterolaemia.

Authors:

Aust Prescr 2019 Feb 13;42(1):29-31. Epub 2018 Dec 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370606PMC
February 2019

The hot patient: acute drug-induced hyperthermia.

Aust Prescr 2019 Feb 1;42(1):24-28. Epub 2019 Feb 1.

Royal Prince Alfred Hospital, Sydney.

Drugs Can Cause Dysregulation Of The Hypothalamic–pituitary–adrenal Axis Which Can Result In A Rise In Core Temperature This Type Of Hyperthermia Is Unresponsive To Antipyretics And Can Be Complicated By Rhabdomyolysis Multi-organ Failure And Disseminated Intravascular Coagulation:

Organic Causes Of Fever Such As Infection Must Be Ruled Out Syndromes Associated With Drug-induced Fever Include Neuroleptic Malignant Syndrome And Anticholinergic Sympathomimetic And Serotonin Toxicity:

The Class Of Offending Drugs As Well As The Temporal Relationship To Starting Or Stopping Them Assists In Differentiating Between Neuroleptic Malignant Syndrome And Serotonin Toxicity:

Immediate Inpatient Management Is Needed The Mainstay Of Management Is Stopping The Drug And Supportive Care Often In The Intensive Care Unit: Read More

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/the-ho
Publisher Site
http://dx.doi.org/10.18773/austprescr.2019.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370613PMC
February 2019
9 Reads

Prescribing for adolescents.

Aust Prescr 2019 Feb 1;42(1):20-23. Epub 2019 Feb 1.

GP Synergy, Sydney.

The Process Of Prescribing Changes As Children Move Into Adulthood For Some Medicines Such As Psychotropic Drugs Safety And Efficacy Are Less Well Understood In Adolescents:

As Adolescents Mature They Attain The Capacity To Consent To Their Own Medical Treatment An Assessment Of Their Competency Will Need To Take Into Account The Nature Of The Treatment Being Proposed:

Parental Involvement Is Usually Beneficial Particularly For Adolescents With Chronic Or Complex Conditions But Increasing Adolescent Autonomy Needs To Be Respected:

Adherence To Treatment Can Be Supported By Understanding Adolescent Development And Involving Adolescents In Management Plans: Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370610PMC
February 2019

Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Aust Prescr 2019 Feb 1;42(1):14-19. Epub 2019 Feb 1.

Department of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne.

Uncomplicated Urinary Tract Infection Is One Of The Most Common Indications For Antibiotic Use In The Community However The Gram-negative Organisms That Can Cause The Infection Are Becoming More Resistant To Antibiotics:

Many Multidrug Resistant Organisms Retain Susceptibility To Two Old Antibiotics Nitrofurantoin And Fosfomycin Advantages Over Newer Drugs Include Their High Urinary Concentrations And Minimal Toxicity:

Fosfomycin Is A Potential Treatment Option For Patients With Uncomplicated Urinary Tract Infection Due To Resistant Organisms Nitrofurantoin May Be More Effective And Can Be Used For Urinary Infections In Pregnant Women: Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370609PMC
February 2019

Prescribing for transgender patients.

Authors:
Louise Tomlins

Aust Prescr 2019 Feb 1;42(1):10-13. Epub 2019 Feb 1.

Taylor Square Private Clinic, Sydney.

With Greater Awareness And Social Acceptance Increasing Numbers Of Transgender Individuals Are Presenting For Gender-affirming Hormone Treatment There Should Be A Full Psychosocial Assessment By An Experienced Clinician Before Hormone Treatment Is Considered:

People Assigned As Males At Birth Who Transition To Female Gender Are Transgender Females Their Management Includes An Estrogen Plus An Anti-androgen:

People Assigned As Females At Birth Who Transition To Male Gender Are Transgender Males Their Hormone Treatment Is Testosterone:

Treatment Is Titrated So That Hormone Concentrations Are Equivalent To The Physiological Concentrations Of The Preferred Gender This Aims To Minimise Adverse Effects: Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370611PMC
February 2019

Optimal antimicrobial duration for common bacterial infections.

Aust Prescr 2019 Feb 1;42(1):5-9. Epub 2019 Feb 1.

Canberra Hospital and Health Services, ACT Health.

Most Antibiotic Use In Australia Arises From Prescriptions In The Community:

The Risk Of Antibiotic-related Adverse Events Including Resistance Increases With Longer Treatment Courses:

When Antibiotics Are Indicated For Treatment Short Courses Are As Effective As Standard Ones For Most Common Infections:

Therapeutic Guidelines Antibiotic Is A Key Reference For Antimicrobial Prescribing In Australia:

General Practitioners Play A Key Role In Reducing Antibiotic Use: Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370607PMC
February 2019

Dry eye: serum eye drops.

Authors:
Phillip Mondy

Aust Prescr 2019 Feb 1;42(1). Epub 2019 Feb 1.

Australian Red Cross Blood Service.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370603PMC
February 2019

Does size matter? Addressing pack size and antibiotic duration.

Aust Prescr 2019 Feb 1;42(1):2-3. Epub 2019 Feb 1.

Mater Health Services, Brisbane.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370608PMC
February 2019

Erratum: 'Cephalosporin allergy' label is misleading [Correction].

Authors:

Aust Prescr 2018 Dec 3;41(6):205. Epub 2018 Dec 3.

[This corrects the article DOI: 10.18773/austprescr.2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299169PMC
December 2018

Nabiximols for multiple sclerosis.

Authors:

Aust Prescr 2018 Dec 18;41(6):203-204. Epub 2018 Oct 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299167PMC
December 2018

Erenumab for migraine.

Authors:

Aust Prescr 2018 Dec 8;41(6):201-202. Epub 2018 Nov 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299170PMC
December 2018

Efmoroctocog alfa for haemophilia A.

Authors:

Aust Prescr 2018 Dec 18;41(6):200. Epub 2018 Oct 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299168PMC
December 2018

Bezlotoxumab for Clostridium difficile.

Authors:

Aust Prescr 2018 Dec 18;41(6):198-199. Epub 2018 Oct 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299171PMC
December 2018

Asfotase alfa for hypophosphatasia.

Authors:

Aust Prescr 2018 Dec 18;41(6):196-197. Epub 2018 Oct 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299166PMC
December 2018

Top 10 drugs 2017-18.

Authors:

Aust Prescr 2018 Dec 3;41(6):194. Epub 2018 Dec 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299179PMC
December 2018

Altering dosage forms for older adults.

Aust Prescr 2018 Dec 3;41(6):191-193. Epub 2018 Dec 3.

College of Medicine and Dentistry, James Cook University, Queensland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299174PMC
December 2018
6 Reads

Insulin pumps in general practice.

Aust Prescr 2018 Dec 3;41(6):186-190. Epub 2018 Dec 3.

Werribee Mercy Hospital, Werribee, Victoria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299172PMC
December 2018

Perimenopausal depression - an under-recognised entity.

Aust Prescr 2018 Dec 3;41(6):183-185. Epub 2018 Dec 3.

Monash Alfred Psychiatry Research Centre, Melbourne, Vic.

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/perime
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299176PMC
December 2018
6 Reads

Home detox - supporting patients to overcome alcohol addiction.

Authors:
Chris Davis

Aust Prescr 2018 Dec 3;41(6):180-182. Epub 2018 Dec 3.

East Sydney Doctors, Sydney, NSW.

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/home-d
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299173PMC
December 2018
8 Reads

Neuropathic pain - definition and drug therapy.

Authors:
Shyan Goh

Aust Prescr 2018 Dec 3;41(6):178-179. Epub 2018 Dec 3.

Meadowbank, Qld.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299178PMC
December 2018

Unpronounceable drug names.

Authors:
Craig Patterson

Aust Prescr 2018 Dec 3;41(6):176-177. Epub 2018 Dec 3.

Australian Medicines Handbook, Adelaide.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299177PMC
December 2018

Safer dispensing labels and paediatric prednisolone.

Aust Prescr 2018 Oct 2;41(5):140. Epub 2018 Oct 2.

Queensland Poisons Information Centre, Brisbane.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202290PMC
October 2018

Ribociclib for breast cancer.

Authors:

Aust Prescr 2018 Oct 2;41(5):172. Epub 2018 Oct 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202289PMC
October 2018

Trifluridine/tipiracil for colorectal cancer.

Authors:

Aust Prescr 2018 Oct 11;41(5):171. Epub 2018 Sep 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202293PMC
October 2018

Dulaglutide for type 2 diabetes.

Authors:

Aust Prescr 2018 Oct 11;41(5):166-168. Epub 2018 Sep 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202295PMC
October 2018

Benralizumab for asthma.

Authors:

Aust Prescr 2018 Oct 11;41(5):164-165. Epub 2018 Sep 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202302PMC
October 2018
1 Read

Dry eye disease: when to treat and when to refer.

Aust Prescr 2018 Oct 1;41(5):160-163. Epub 2018 Oct 1.

University of Melbourne.

Dry Eye Disease Affects One In Five Adults And Can Significantly Impair Quality Of Life Most Patients Have Mild Disease:

This Condition Is Multifactorial With An Inflammatory Component Which Can Markedly Worsen The Impact On The Ocular Surface Meibomian Gland Dysfunction Is Extremely Common In Dry Eye Disease And Contributes To The Inflammatory Process:

Management Of Mild Disease Includes Identifying And Removing Precipitants And Symptomatic Treatment With Artificial Tear Supplements:

More Advanced Disease Requires Management Of Underlying Ophthalmic And Systemic Conditions As Well As More Aggressive Therapies To Protect The Ocular Surface: Read More

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/dry-ey
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202299PMC
October 2018
10 Reads

Medical management of metastatic prostate cancer.

Aust Prescr 2018 Oct 2;41(5):154-159. Epub 2018 Oct 2.

Department of Medical Oncology, Canberra Hospital.

Androgen Deprivation Therapy Has An Important Role In The Medical Treatment Of Advanced And Metastatic Prostate Cancer:

The Treatment Of Metastatic Prostate Cancer Is Influenced By Whether The Patient’s Disease Has Progressed On Androgen Deprivation Therapy Or Not It Is Considered To Be Castrate-resistant Disease If The Cancer Has Progressed Despite Adequate Suppression Of Androgens:

Chemotherapy Using Docetaxel Or Cabazitaxel And Anti-androgen Drugs Such As Abiraterone And Enzalutamide Can Be Used To Treat Castrate-resistant Disease Radium-223 Is An Option For Patients With Bony Metastases:

Metastatic Castrate-resistant Prostate Cancer Is Now Considered A Chronic Illness As The Life Expectancy Of Patients Has Almost Doubled Due To The New Treatments General Practitioners Are Therefore More Likely To Encounter Patients With Disease- And Treatment-related Complications: Read More

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/medica
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202297PMC
October 2018
17 Reads

Drugs for benign prostatic hypertrophy.

Aust Prescr 2018 Oct 1;41(5):150-153. Epub 2018 Oct 1.

Royal Brisbane and Women's Hospital.

Benign Prostatic Hyperplasia Is A Common Condition It Can Cause Problems With Urine Storage And Voiding And The Severity Of Symptoms May Be Unrelated To The Size Of The Prostate:

When Drug Treatment Is Required Benign Prostatic Hyperplasia Can Be Managed With Monotherapy Or Combination Therapy Most Patients Are Managed With Selective Alpha Blockers:

Patients With Larger Prostate Volumes May Benefit From A 5-alpha-reductase Inhibitor Usually In Combination With An Alpha Blocker: Read More

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/drugs-
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202296PMC
October 2018
14 Reads

Treatment of irritable bowel syndrome.

Aust Prescr 2018 Oct 1;41(5):145-149. Epub 2018 Oct 1.

St Vincent's Hospital, Melbourne.

Irritable Bowel Syndrome Is A Chronic Functional Gastrointestinal Disorder That Presents With Abdominal Pain Related To Defecation Accompanied By A Change In Stool Frequency Or Form Despite Its Impact On A Patient’s Quality Of Life It Has No Effect On Mortality:

A Positive Clinical Diagnosis Should Be Made If The Characteristic Symptoms Are Present And Red Flags Are Absent Red Flags Should Prompt Specialist Referral:

Consultations Should Be Provided In An Empathetic Manner Addressing The Concerns Of The Patient While Providing Reassurance:

Manipulating Diet With The Assistance Of A Dietitian Is An Appropriate Initial Treatment For Irritable Bowel Syndrome A Low-fodmap Diet Is An Effective Therapy: Read More

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/treatm
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202292PMC
October 2018
13 Reads

Second steps in managing type 2 diabetes.

Aust Prescr 2018 Oct 2;41(5):141-144. Epub 2018 Oct 2.

Canberra Hospital and Health Services.

In Type 2 Diabetes Diet Exercise And Attaining A Healthy Weight Should Be Encouraged At Every Opportunity:

Metformin Is The Usual First-line Drug Management:

Sulfonylureas Are Appropriate As Second-line Drugs For Many Patients Other Oral Drugs Are Preferable If Weight Gain Or Hypoglycaemia Are Significant Problems:

If A Combination Of Metformin And A Sulfonylurea Is Not Suitable Either A Dipeptidyl Peptidase-4 Inhibitor Or Sodium-glucose Co-transporter 2 Inhibitor Can Be Prescribed The Patient Characteristics And The Beneficial And Adverse Effects Of The Drug Should Be Considered When Selecting Second-line Therapy:

Due To Their Adverse-effect Profiles Thiazolidinediones And Acarbose Should Be Reserved For Patients With Contraindications To All Other Oral Drugs And Those Who Will Not Tolerate Injectable Drugs: Read More

View Article

Download full-text PDF

Source
https://www.nps.org.au/australian-prescriber/articles/second
Publisher Site
http://dx.doi.org/10.18773/austprescr.2018.043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202300PMC
October 2018
10 Reads

Reducing medicine waste in aged care.

Authors:
Leah Curtis

Aust Prescr 2018 Oct 1;41(5):139. Epub 2018 Oct 1.

Melbourne.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202298PMC
October 2018

Automated adverse drug reaction detection.

Authors:
Claire Keith

Aust Prescr 2018 Oct 1;41(5):138. Epub 2018 Oct 1.

Austin Health, Melbourne.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202301PMC
October 2018

Medicine shortages in Australia - what are we doing about them?

Authors:
Steve Morris

Aust Prescr 2018 Oct 1;41(5):136-137. Epub 2018 Oct 1.

SA Pharmacy, Adelaide.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202294PMC
October 2018
9 Reads

Labels for prescription medicines.

Authors:
Ashok Chotai

Aust Prescr 2018 Aug 1;41(4):101. Epub 2018 Aug 1.

Brisbane.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091771PMC

Silodosin for benign prostatic hypertrophy.

Authors:

Aust Prescr 2018 Aug 12;41(4):129-130. Epub 2018 Jun 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091779PMC

Palbociclib for breast cancer.

Authors:

Aust Prescr 2018 Aug 12;41(4):127-128. Epub 2018 Jun 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091774PMC

Ocrelizumab for multiple sclerosis.

Authors:

Aust Prescr 2018 Aug 12;41(4):125-126. Epub 2018 Jun 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091782PMC

Atezolizumab for non-small cell lung cancer.

Authors:

Aust Prescr 2018 Aug 12;41(4):124. Epub 2018 Jun 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091778PMC

Communication and ciprofloxacin-associated acute kidney injury.

Aust Prescr 2018 Aug 1;41(4):122. Epub 2018 Aug 1.

Renal Medicine, Canberra Hospital and Community Services.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091775PMC
August 2018
2 Reads

Brief interventions for alcohol and other drug use.

Authors:
Craig Rodgers

Aust Prescr 2018 Aug 1;41(4):117-121. Epub 2018 Aug 1.

Alcohol and Drug Service, St Vincent's Hospital, Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2018.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091783PMC